Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(17%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_4
2
17%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(6)
Other(4)

Detailed Status

Completed6
unknown4
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (16.7%)
N/A10 (83.3%)

Trials by Status

recruiting217%
completed650%
unknown433%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12